Medicine sales value share in Russia 2020-2023, by origin

Published by Statista Research Department, May 10, 2024

In 2023, pharmaceuticals of foreign origin comprised the largest share of Russian pharmaceutical commercial sales of medicines in monetary terms, at 51.9 percent. The share of revenue from domestic drug sales slightly increased from the previous year.

Distribution of commercial medicine sales revenue in Russia from 2020 to 2023, by origin

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2024

Region

Russia

Survey time period

2020 to 2023

Supplementary notes

The statistic has been compiled from several reports by the source.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Russia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Russia

Overview

8

Segments

8

Companies and brands

8

Pharmacies

4

Online retail

6

Trade

4

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in RussiaGlobal pharmaceutical industryTop pharmaceutical drugsHealthcare in RussiaCoronavirus (COVID-19) in Russia
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.